GlassScriptPhysician profile
Steven I Zelin
NPI 1235263138
$321.19
in general payments reported to CMS, 2019-2025
8 companies · $69.36 in 2025
The $69.36 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.38 · 2020: $14.16 · 2023: $138 · 2024: $54.55 · 2025: $69.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $123.04 | 2023 | Watchman Flx |
| Merck Sharp & Dohme LLC | $47.77 | 2019-2025 | Bridion |
| Hemosonics LLC | $34.14 | 2025 | Qunatra Qplus System, Quantra Qplus System |
| Fisher & Paykel Healthcare INC | $31.87 | 2024 | Fisher & Paykel Healthcare |
| Mallinckrodt Enterprises LLC | $30.47 | 2019 | |
| Mindray Ds USA, INC. | $22.68 | 2024 | A7 Anesthesia System |
| Haemonetics Corporation | $16.52 | 2025 | Teg6s Hemostasis System |
| Silk Road Medical, INC. | $14.70 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zelin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.